A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants

NCT04023877 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementias With Lewy Bodies

Interventions

DRUG: E2027

Sponsor

Eisai Inc.